Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2026)
Sunshine Biopharma (SBFM) reported Change in Taxes of $175.0 for Q1 2026, up 100.44% on a YoY basis from $87.31 in Q1 2025, and up 100.11% quarter-over-quarter from -$152874.0 in Q4 2025.
Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2026) Analysis & Trends
Sunshine Biopharma has reported Change in Taxes for 5 years, with the latest figure at $175.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes rose 100.44% year-over-year to $175.0; the trailing twelve-month figure through Mar 2026 stood at $40336.0 (up 104.99% YoY), and the FY2024 full-year result was -$812080.0, down 1008.69% from the prior year.
- Change in Taxes for Q1 2026 stood at $175.0, up from -$152874.0 in the prior quarter.
- The five-year high for Change in Taxes was $1.0 million in Q4 2023, with the low at -$1.2 million in Q2 2024.
- Historically, Change in Taxes has averaged -$46176.6 across 5 years, with a median of -$19993.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Taxes surged 323.55% — and 2024, when it tumbled 530.84%.
- Sunshine Biopharma's Change in Taxes stood at $238679.0 in 2022, then surged by 323.55% to $1.0 million in 2023, then plunged by 108.35% to -$84452.0 in 2024, then sank by 81.02% to -$152874.0 in 2025, then surged by 100.11% to $175.0 in 2026.
- The last three Change in Taxes figures came in at $175.0 (Q1 2026), -$152874.0 (Q4 2025), and $162992.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 73.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 119.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | 175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175.00 |
| Mar 31, 2026 | 175.00 |
| Dec 31, 2025 | -152,874.00 |
| Dec 31, 2025 | -152,874.00 |
| Sep 30, 2025 | 162,992.00 |
| Sep 30, 2025 | 162,992.00 |
| Jun 30, 2025 | 30,043.00 |
| Jun 30, 2025 | 30,043.00 |
| Mar 31, 2025 | -40,161.00 |
| Mar 31, 2025 | -40,161.00 |
| Dec 31, 2024 | -84,452.00 |
| Dec 31, 2024 | -84,452.00 |
| Sep 30, 2024 | 520,043.00 |
| Sep 30, 2024 | 520,043.00 |
| Jun 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -43,824.00 |
| Mar 31, 2024 | -43,824.00 |
| Dec 31, 2023 | 1.01 Mn |
| Dec 31, 2023 | 1.01 Mn |